Border Medical Oncology Research Unit

Site:	Border Medical Oncology Research Unit
Address:
City:	Albury
State:	NSW
Zip:
Country:	Australia

Phase	Trial [asc]	Trial Status	Site Status	Drug	NCT#
3	A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib (intrigue)	Active, not recruiting	Active	QINLOCK Ripretinib DCC-2618 SUTENT Sunitinib	NCT03673501